Roles of T lymphocytes in pulmonary fibrosis
The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
Infiltration of T lymphocytes in the lungs is common in patients with and in animal models of pulmonary fibrosis. The role of these cells in regulating the accumulation of extracellular matrix, particularly collagen, is not understood completely. Research literature provides evidence for a profibrotic, an antifibrotic, or no significant role of T lymphocytes in pulmonary fibrosis. This review offers a discussion of such evidence with the focus on phenotypes of pulmonary T lymphocytes and related profibrotic and antifibrotic mechanisms. It appears unlikely that T lymphocytic infiltration per se is the central driving force in most cases of pulmonary fibrosis. Instead, evidence suggests that T lymphocytes may modulate the inflammatory and healing responses in the lungs in a profibrotic or antifibrotic manner, depending on their phenotype. Phenotypic reshaping, rather than elimination of the infiltrating pulmonary T lymphocytes, may be a promising approach to improving outcomes in patients with pulmonary fibrosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Here, Th1 cells and their secretory products are thought of as being anti-fibrotic and Th2 cells and their mediators are considered pro-fibrotic (133).”
From The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis (2018) · cites this paper as [133]
Citations
Cites
Incidence and Prevalence of Idiopathic Pulmonary Fibrosis
Raghu, G., Weycker, D., Edelsberg, J., Bradford, W. Z., & Oster, G. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200602-163oc · Cited by 1,310 · cited 2×
“new patients per year in the United States [2].”
BackgroundIdiopathic Pulmonary Fibrosis: Clinical Relevance of Pathologic Classification
KATZENSTEIN, A.-L. A., & MYERS, J. L. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.4.9707039 · Cited by 1,261
IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines
Molet, S., Hamid, Q., Davoineb, F., Nutku, E., Tahaa, R., Pagé, N., Olivenstein, R., Elias, J., & Chakir, J. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.117929 · Cited by 953 · cited 1×
“IL-17 enhances production of cytokines in cultured, pulmonary fibroblasts but appears to have no direct effect on fibroblast proliferation or collagen production [52].”
BackgroundA placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis
Raghu, G., Brown, K. K., Bradford, W. Z., Starko, K., Noble, P. W., Schwartz, D. A., & King, T. E. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030511 · Cited by 652
Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis.
Piguet, P. F., Collart, M. A., Grau, G. E., Kapanci, Y., & Vassalli, P. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.3.655 · Cited by 583 · cited 1×
“In contrast, different studies in the bleomycin model reported that depletion of T cells prevents collagen accumulation [34] or diminishes pulmonary fibrosis and increases survival [35].”
ResultA Vicious Circle of Alveolar Macrophages and Fibroblasts Perpetuates Pulmonary Fibrosis via CCL18
Prasse, A., Pechkovsky, D. V., Toews, G. B., Jungraithmayr, W., Kollert, F., Goldmann, T., Vollmer, E., Müller-Quernheim, J., & Zissel, G. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200509-1518oc · Cited by 497 · cited 1×
“For example, activation of alveolar macrophages with type 2 cytokines skews their phenotype toward so-called alternative activation, and alternatively activated macrophages are themselves profibrotic [49] through production of various cytokines including profibrotic chemokines CCL2 [42] and CCL18 [50, 51].”
BackgroundBleomycin-induced interstitial pulmonary disease in the nude, athymic mouse.
Szapiel, S. V., Elson, N., Fulmer, J. D., Hunninghake, G. W., & Crystal, R. G. (1979) · PubMed · doi:10.1164/arrd.1979.120.4.893 · Cited by 463 · cited 1×
“Mice with genetic defects manifesting in a total lack of T lymphocytes, such as athymic (nude) mice [27] and SCID mice [28], developed alveolitis and pulmonary fibrosis in response to bleomycin, similar to that in normal (wild-type) mice.”
BackgroundDANIIL, Z. D., GILCHRIST, F. C., NICHOLSON, A. G., HANSELL, D. M., HARRIS, J., COLBY, T. V., & du BOIS, R. M. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.3.9903021 · Cited by 381
Mart�nez-Lav�n, M., Hermosillo, A. G., Rosas, M., & Soto, M.-E. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199811)41:11<1966::aid-art11>3.0.co;2-o · Cited by 306
Structural Features of Interstitial Lung Disease in Systemic Sclerosis
Harrison, N. K., Myers, A. R., Corrin, B., Soosay, G., Dewar, A., Black, C. M., Du Bois, R. M., & Turner-Warwick, M. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/144.3_pt_1.706 · Cited by 251 · cited 2×
“Pulmonary fibrosis often occurs in association with systemic connective tissue diseases, particularly scleroderma [4, 12], rheumatoid arthritis (RA) [14], and polymyositis/dermatomyositis [15, 16].”
Background
Research works printed but not linked: 1
- Huaux, 2007, ThIL-17 cells contribute to alveolitis but are not instrumental in fibrosis development, Am. J. Respir. Crit. Care Med., 175, A737
Cited by
Items 101–182 of 182
Clinical implication of protease-activated receptor-2 in idiopathic pulmonary fibrosis
Park, Y. S., Park, C. M., Lee, H. J., Goo, J. M., Chung, D. H., Lee, S., Yim, J., Kim, Y. W., Han, S. K., & Yoo, C. (2012) · Respiratory Medicine · doi:10.1016/j.rmed.2012.10.011 · Cited by 18
O’Flaherty, B. M., Matar, C. G., Wakeman, B. S., Garcia, A., Wilke, C. A., Courtney, C. L., Moore, B. B., & Speck, S. H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135719 · Cited by 18
“described T cells as an important component cell type of inflammation—likely affecting fibrosis through a diverse set of mechanisms—though not the driving force of IPF, perhaps these T cells modulate the severity of fibrosis [61].”
BackgroundEffect and Safety of Mycophenolate Mofetil in Idiopathic Pulmonary Fibrosis
Τzouvelekis, Α., Bouros, E., Oikonomou, A., Ntolios, P., Zacharis, G., Kolios, G. C., & Bouros, D. (2011) · Pulmonary Medicine · doi:10.1155/2011/849035 · Cited by 18
“It is therefore conceivable to speculate that the inability of the drug to be proven efficacious lies both in the previously suggested minor contribution of T cells in the pathogenesis of IPF [32] as well as in the inevitable progressive clinical course.”
BackgroundCD4+CD25+ Tregs as dependent factor in the course of bleomycin-induced pulmonary fibrosis in mice
Zhang, J.-H., Deng, J.-H., Yao, X., Wang, J., & Xiao, J. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.111700 · Cited by 17
Huang, L., Yang, X., Feng, Y., Huang, H.-X., Hu, J.-Q., Yan, P., Pan, H., & Xie, Y. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118755 · Cited by 17
Sun, X., Zhang, X., He, Y., Du, X., Cai, Q., & Liu, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1562892 · Cited by 17
“Cytotoxic CD8 + T cells, recognized for their ability to eliminate virus-infected and tumor cells through both membrane-bound and soluble cytotoxic mechanisms, may also in fl uence fi broblast activity (51).”
Li, C. R., He, Y., Zhang, Y., You, Y., Yuan, H.-Y., Wei, Y., Chen, X., & Chen, J. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113173 · Cited by 17
Luzina, I. G., Lockatell, V., Todd, N. W., Kopach, P., Pentikis, H. S., & Atamas, S. P. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.224675 · Cited by 17
“1, C and D, and 2, C and D), an observation that is consistent with previous reports (Pochetuhen et al., 2007; Luzina et al., 2008, 2013) and models similar changes in human patients with ILD (Atamas et al., 1999; Luzina et al., 2003, 2008, 2009; Todd et al., 2013; Kropski et al., 2015) that are…”
BackgroundResultInfluentialSelf-citationCCR6 is not necessary for functional effects of human CCL18 in a mouse model
Luzina, I. G., & Atamas, S. P. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-2 · Cited by 17
“Further research is necessary to identify CCL18 receptor(s), as the CCL18-dependent pathway is centrally involved in a variety of maladies, particularly Tlymphocyte-mediated fibrotic pulmonary diseases [1].”
BackgroundSelf-citationTsukalov, I., Sánchez‐Cerrillo, I., Rajas, O., Ávalos, E., Iturricastillo, G., Esparcia, L., Buzón, M. J., Genescà, M., Scagnetti, C., Popova, O., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46322-8 · Cited by 16
“Moreover, Th2 polarized response is asso-ciatedwiththepulmonary fi brosisdevelopment 105 .”
BackgroundFibrotic hypersensitivity pneumonitis
Pérez, E. R. F., & Brown, K. K. (2014) · Current Respiratory Care Reports · doi:10.1007/s13665-014-0094-0 · Cited by 13
Mechanotherapy: Modulating immune cell function in tissue regeneration and fibrosis
Ward, N. A., Prendeville, H., Wallace, E. J., Shokrani, P., Trask, L., Dillon, R., Beatty, R., Roche, E. T., Duffy, G. P., & Dolan, E. B. (2025) · Acta Biomaterialia · doi:10.1016/j.actbio.2025.08.048 · Cited by 11
Activation of the P2RX7/IL-18 pathway in immune cells attenuates lung fibrosis
Hreich, S. J. D., Juhel, T., Leroy, S., Ghinet, A., Brau, F., Hofman, V., Hofman, P. M., & Vouret‐Craviari, V. (2023) · eLife · doi:10.7554/elife.88138.4 · Cited by 10
Store-Operated Ca 2+ Entry in Fibrosis and Tissue Remodeling
Abdelnaby, A. E., & Trebak, M. (2024) · Contact · doi:10.1177/25152564241291374 · Cited by 10
“For instance, in idiopathic pulmonary fi brosis (IPF) and the unilateral ureteral obstruction (UUO) models, IFN-γ may exert anti-fi brotic effects, highlighting the dual and often contradictory roles of Th1-derived cytokines in fi brosis (Luzina et al., 2008; Dong et al., 2016).”
Hu, Y., Qian, C., Sun, H., Li, Q., Wang, J., Hua, H.-R., Dai, Z., Li, J., Li, T., Ding, Y., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112153 · Cited by 10
Τzouvelekis, Α., Karampitsakos, Τ., Bouros, E., Tzilas, V., Liossis, S. C., & Bouros, D. E. (2019) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2019.06.002 · Cited by 9
Lehtonen, S. T., Karvonen, H. M., Harju, T. H., Sormunen, R. T., Lappi‐Blanco, E., Hilli, M., Risteli, J., Merikallio, H., & Kaarteenaho, R. L. (2013) · Apmis · doi:10.1111/apm.12146 · Cited by 9
“It has been previously reported that both lymphocytes, macrophages and cytokines secreted by them can affect fibroblast proliferation (31, 32).”
BackgroundTowards Treatable Traits for Pulmonary Fibrosis
Hoffman, T. W., & Grutters, J. C. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12081275 · Cited by 9
“The presence of inflammatory cells in regions of tissue fibrosis can even be interpreted as their being part of an antifibrotic feedback loop [65].”
BackgroundAnti-Fibrotic and Anti-Inflammatory Role of NO-Sensitive Guanylyl Cyclase in Murine Lung
Englert, N., Burkard, P., Aue, A., Rosenwald, A., Nieswandt, B., & Friebe, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411661 · Cited by 9
“Several subtypes of CD4-positive T helper lymphocytes have been identified to trigger milieu-dependent anti- or pro-fibrotic processes [10,11].”
BackgroundSo, R. J., Collins, S. L., Collins, S., Mafla, L. M., Chan‐Li, Y., Lina, I. A., Gelbard, A. H., Motz, K., & Hillel, A. T. (2024) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2024.2886 · Cited by 8
Piao, C., Zhuang, C., Ko, M. K., Hwang, D. W., & Lee, M. (2022) · Journal of drug targeting · doi:10.1080/1061186x.2022.2069781 · Cited by 8
“Inflammatory reactions can interfere with normal repair of damaged alveolar epithelial cells; as a result, fibroblasts proliferate rapidly, and ECM proteins such as collagen accumulate in the damaged area [10,11].”
BackgroundAtamas, S. P., Luzina, I. G., Ingels, J. F., Choi, J., Wong, W. K., Furst, D. E., Clements, P. J., Investigators of the Oral Collagen Trial in Scleroderma, & Postlethwaite, A. E. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04189.x · Cited by 8
Self-citationInvolvement of Lymphocyte Infiltration in the Progression of Mouse Peritoneal Fibrosis Model
Nishino, T., Ashida, R., Obata, Y., Furusu, A., Abe, K., Miyazaki, M., Koji, T., & Kohno, S. (2012) · Renal Failure · doi:10.3109/0886022x.2012.676527 · Cited by 8
Xu, Q., Zhu, W., Tang, M., Zhang, M., Liu, Y., Li, Z., Rao, Z., He, X., Ma, R., & Xue, X. (2023) · Cytokine · doi:10.1016/j.cyto.2023.156188 · Cited by 7
Ghazanfari, T., Rezaei, A., Rezaei, R., Kariminia, A., Naghizadeh, M. M., Soroush, M., Shams, J., Faghihzadeh, S., & Hassan, Z. M. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113851 · Cited by 7
Human lung fibroblasts increase CD4(+)CD25(+)Foxp3(+) T cells in co-cultured CD4(+) lymphocytes
Conte, E., Gili, E., Fruciano, M., Fagone, E., & Vancheri, C. (2013) · Cellular Immunology · doi:10.1016/j.cellimm.2013.09.002 · Cited by 6
Regulatory T Cells and Lung Fibrosis: A Good Cell Gone Bad
Atamas, S. P., & Fontenot, A. P. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201108-1572ed · Cited by 6
“Whether inflammatory and immune mechanisms contribute to pulmonary fibrosis remains an issue of continued debate, with substantial focus on the possible pathophysiological roles of T lymphocytes, which may be either pro- or antifibrotic depending on the specific cell population (2).”
BackgroundSelf-citationTan, Y., Qian, B., Ma, Q., Xiang, K., & Wang, S. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s489210 · Cited by 5
Role of Immune Cells in the Initiation and Progression of Pulmonary Fibrosis
Soumyakrishnan, S., Ayariga, J. A., Sreepriya, M., & Sudhandiran, G. (2022) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2023047301 · Cited by 5
Perera, K. U. E., Organ, L. A., Royce, S. G., Samuel, C. S., Derseh, H. B., Dewage, S. N. V., Koumoundouros, E., Stent, A. W., & Snibson, K. J. (2023) · Canadian Respiratory Journal · doi:10.1155/2023/1522593 · Cited by 5
Yan, M., Wang, Q., Yang, H., Liu, D., Liang, W., & Chen, H. (2025) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-025-01770-x · Cited by 5
“T-cell in fi ltration into the lungs was frequently observed in fi brosis patients and animal models [18].”
Cohen, P. Y., Breuer, R., Zisman, P., & Wallach‐Dayan, S. B. (2015) · Mediators of Inflammation · doi:10.1155/2015/942179 · Cited by 5
Pericytes and T Cells in Lung Injury and Fibroproliferation
Birbrair, A., Prazeres, P. H. D. M., Files, D. C., & Delbono, O. (2018) · Molecular and translational medicine · doi:10.1007/978-3-319-98143-7_7 · Cited by 4
Up‐regulated integrinα4β1 on systemic lymphocytes and serum IL ‐17 A in interstitial pneumonia
Taooka, Y., Ohe, M., Tada, M., Sutani, A., & Isobe, T. (2015) · The Clinical Respiratory Journal · doi:10.1111/crj.12277 · Cited by 4
“Integrinα4β1 expressed not only on Th1 cells, but also on Th17 cells, and dominantly expressed on Th1 cells (7, 13).”
BackgroundLemay, A., & Haston, C. K. (2018) · Radiation Research · doi:10.1667/rr15144.1 · Cited by 4
“(31) for the T-lymphocyte contribution to lung fibrosis.”
BackgroundElewa, Y. H. A., Ichii, O., Nakamura, T., & Kon, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.665100 · Cited by 4
“infiltration of T lymphocytes in the lungs contributed to the progression of pulmonary fibrosis through a profibrotic function or recovery from fibrosis through an antifibrotic role (30).”
BackgroundRole of matrix metalloproteases in pulmonary fibrosis
Pardo, A., & Selman, M. (2008) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8585-9_3 · Cited by 4
Relief from Within: A Peptide Therapy for Fibrosis
Atamas, S. P. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004138 · Cited by 4
Self-citationMycophenolate and azathioprine in fibrotic interstitial lung disease
Pugashetti, J. V., Jee, A. S., Yu, A. R. M., Hammoud, N., Chua, F., Yazbeck, L., Lee, C. T., Liu, G. Y., Adams, T. N., Adegunsoye, A., et al. (2026) · American Journal of Respiratory and Critical Care Medicine · doi:10.1093/ajrccm/aamag362 · Cited by 3
Sgambellone, S., Febo, M., Durante, M., Marri, S., Villano, S., Bereshchenko, O., Migliorati, G., Masini, E., Riccardi, C., Bruscoli, S., et al. (2023) · Inflammation Research · doi:10.1007/s00011-023-01802-3 · Cited by 3
“We also evaluated the presence of variations in the expression of the CCL2 and CCR2, a chemokine and its receptor essential for regulating T cell infiltration [36].”
BackgroundMethodLe récepteur B1 des kinines dans la fibrose rénale : des mécanismes au potentiel thérapeutique
Klein, J. (2009) · Thèses en ligne de l'Université Toulouse III (Université Toulouse III) · Cited by 3
Yao, L., Liu, B., & Wang, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-01759-9 · Cited by 2
Protective role of natural products in pulmonary fibrosis through immuneregulation
Su, Y., Che, X., Chen, Y., Wu, X., Wang, J., Jiang, Z., & Li, X. (2026) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(26)61074-6 · Cited by 2
Matsuyama, S., Pervin, M., Nakagawa, M., Izawa, T., Kuwamura, M., & Yamate, J. (2021) · Journal of Veterinary Medical Science · doi:10.1292/jvms.21-0341 · Cited by 2
“It is likely that M1/M2 macrophages and T cells reacting to CD4 and CD8 contribute complicatedly to renal fibrosis [8, 10].”
BackgroundGibson, D. L., Montero, M., Ryz, N. R., & Vallance, B. A. (2009) · Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry · doi:10.2174/187152309789152002 · Cited by 2
Cappuccini, F. (2017) · DuEPublico (University of Duisburg-Essen) · Cited by 1
Muhammad, O., & Ahmed, S. M. (2015) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York) · Cited by 1
WITHDRAWN: γδ T cells and Th17 cytokines in hypersensitivity pneumonitis and lung fibrosis
Simonian, P. L., Roark, C. L., Born, W. K., O’Brien, R. L., & Fontenot, A. P. (2009) · Translational research · doi:10.1016/j.trsl.2009.07.011 · Cited by 1
RetractedCarpenter, M. (2010) · University of Birmingham Institutional Research Archive (University of Birmingham) · Cited by 1
Wong, S. C. (2013) · MacSphere (McMaster University) · doi:10.71548/11303 · Cited by 1
Regulation of liver X receptors by microRNA-155 in pulmonary fibrosis
Hasoo, M. K. (2013) · Enlighten: Theses (The University of Glasgow)
Rey, F., & Tamara, M. (2013) · DIGITAL.CSIC (Spanish National Research Council (CSIC))
Encapsulating Peritoneal Sclerosis: A study on pathophysiology, clinical aspects and management
Habib, M. S. (2014) · EUR Research Repository (Erasmus University Rotterdam)
Fibrocytes in Scleroderma-Related Interstitial Lung Disease
Mathai, S. K., & Herzog, E. L. (2011) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814343725_0010
Olodaterol in model systems of fibrosis
Herrmann, F. E. (2017) · KOPS (University of Konstanz)
Lee, J. S., & Fontenot, A. P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-7020-6896-6.00072-7
Hojabrpour, P. (2019) · cIRcle (University of British Columbia) · doi:10.14288/1.0371943
“The involvement of skewed T Helper type 1 and 2 cells (Th1, Th2) imbalance has shown to modulate the fibrosis effect during early stages of the IPF [50].”
BackgroundFontenot, A. P., & Simonian, P. L. (2013) · Elsevier eBooks · doi:10.1016/b978-0-7234-3691-1.00085-4
Is Immune Response Relevant in Interstitial Lung Disease?
Khan, M. M. (2020) · Current Immunology Reviews · doi:10.2174/1573395516999200914143054
Khaliullin, T. O. (2020) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.7820
Adaptive Immunity in Interstitial Lung Disease
Winkler, J., & Herzog, E. L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-08-102723-3.00018-4
Features of a telomere syndrome in patients with idiopathic pulmonary fibrosis
Hoffman, T. W. (2023) · Utrecht University Repository (Utrecht University) · doi:10.33540/1359
Activation of the P2RX7/IL-18 pathway in immune cells attenuates lung fibrosisPreprint
Hreich, S. J. D., Juhel, T., Leroy, S., Ghinet, A., Brau, F., Hofman, V., Hofman, P. M., & Vouret‐Craviari, V. (2023) · eLife · doi:10.7554/elife.88138.1
Author Response: Activation of the P2RX7/IL-18 pathway in immune cells attenuates lung fibrosis
Hreich, S. J. D., Juhel, T., Leroy, S., Ghinet, A., Brau, F., Hofman, V., Hofman, P. M., & Vouret‐Craviari, V. (2023) · eLife · doi:10.7554/elife.88138.1.sa4
Author Response: Activation of the P2RX7/IL-18 pathway in immune cells attenuates lung fibrosis
Hreich, S. J. D., Juhel, T., Leroy, S., Ghinet, A., Brau, F., Hofman, V., Hofman, P. M., & Vouret‐Craviari, V. (2024) · eLife · doi:10.7554/elife.88138.4.sa3
Rôle de l'immunomodulateur P2RX7 dans le cancer et la fibrose pulmonaire
Hreich, S. J. D. (2022) · theses.fr (ABES) · doi:10.70675/4b399e7fzb436z4e8fz8045z90c0862c799d
Biomarkers and phenotype concepts in sarcoidosis care
Schimmelpennink, M. C. (2024) · Utrecht University Repository (Utrecht University) · doi:10.33540/2085
Ohfuji, S. (2025) · Journal of Comparative Pathology · doi:10.1016/j.jcpa.2025.05.006
Singh, R. K., Pradhan, A. K., Roy, D., Arya, M., Chakravarti, R., Dutta, D., Kundu, A., Bhaduri, S., Singh, P., Kazi, T. A., et al. (2025) · Respiratory Medicine · doi:10.1016/j.rmed.2025.108519
Activation of TSLP–IL-9 Axis Hinders the Antifibrotic Effect of ST2 Deficiency in Pulmonary Fibrosis
Atamas, S. P., Lockatell, V., Mei, Z., Tulapurkar, M. E., Lugkey, K. N., Krupnick, A. S., & Luzina, I. G. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262411787
“The pathophysiology of pulmonary fibrosis in general, including the complexity of the pro-and antifibrotic regulation by immune mechanisms, remains far from fully understood [1–6].”
Self-citationDie Rolle der NO-sensitiven Guanylyl-Cyclase in der Lungenfibrose der Maus
Englert, N. (2024) · Online Publication Service of Würzburg University (Würzburg University) · doi:10.25972/opus-34805
CCL18 als serologischer Verlaufsparameter bei der Sarkoidose
Thies, K. (2013) · FreiDok plus (Universitätsbibliothek Freiburg)
The role of the Four and a half LIM only protein 2 (FHL2) in bleomycin induced lung fibrosis
Alnajar, A. (2013) · URN:NBN Resolver for Germany & Switzerland (German National Library)
Ziekte van Peyronie: moleculaire biologie en nieuwe behandelingsopties
Milenkovic, U. (2019) · Lirias
Bantsimba-Malanda, C. (2009) · theses.fr (ABES) · doi:10.70675/b5564f90zc43cz4a7az9e2dzf77a62264eff
Goda, S., Yamada, T., Goto, Y., Uda, S., Nakao, A., Shiotsu, S., Kukida, Y., Tanimura, K., Miyamoto, A., Imasato, Y., et al. (2026) · BMC Pulmonary Medicine · doi:10.1186/s12890-026-04347-3
“Generally, T H 1 cells and their secretory products exert anti-fibrotic effects, whereas T H 2 cells, T H 17 cell sub-sets, and their mediators are considered pro-fibrotic [43, 44].”
Activation of the P2RX7/IL-18 pathway in immune cells attenuates lung fibrosisPreprint
Hreich, S. J. D., Juhel, T., Leroy, S., Ghinet, A., Brau, F., Hofman, V., Hofman, P. M., & Vouret‐Craviari, V. (2023) · eLife · doi:10.7554/elife.88138.2
Yang, Z., 李慧星, Qin, C., Luo, Y., Li, Z. B., Yin, Y. M., Jingyu, C., Pu, Z., & Wang, T. (2026) · Annals of Medicine · doi:10.1080/07853890.2026.2745489
Takahashi, M., Mizumura, K., Gon, Y., Tetsuo Shimizu, Kozu, Y., Sotaro Shikano, Yuko Iida, Hikichi, M., Shinichi Okamoto, Tsuya, K., et al. (2022) · doi:10.3389/fphar.2021.643980.s001
Metadata
- Authors
- Luzina, I. G., Todd, N. W., Iacono, A. T., & Atamas, S. P.
- Affiliations
- Baltimore VA Medical Center (US)
- Corresponding author
- Atamas, Sergei P
- Venue
- Journal of Leukocyte Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-10-25
- Volume
- 83
- Issue
- 2
- Pages
- 237-244
- ISSN
- 0741-5400 (ISSN-L)
- 1938-3673
- OpenAlex
- W2164998164
- Cited by
- 163
- References
- 59
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 7 · 2023: 12 · 2022: 12 · 2021: 7 · 2020: 9 · 2019: 7 · 2018: 13 · 2017: 9 · 2016: 8 · 2015: 10 · 2014: 8 · 2013: 10 · 2012: 12
- FWCI
- 0.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Leukocyte Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1R01HL074067)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Keywords
- pulmonary fibrosis, T cells, T cell phenotype, extracellular matrix accumulation, collagen deposition, antifibrotic mechanism, lung inflammation
- MeSH terms
- Animals, Connective Tissue Diseases, Disease Models, Animal, Extracellular Matrix, Humans, Inflammation, Lymphocyte Depletion, Lymphokines, Mice, Nude, Pulmonary Fibrosis, T-Lymphocyte Subsets, Mice, SCID, Lung Diseases, Interstitial, CD28 Antigens, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.